Close Menu

depression

The toolkit is the first product released under the Consensus Measures for Phenotypes and eXposures initiative, which is a three-year project aimed at developing a set of standard measures across 20 research categories related to health and common diseases.

The approximately $17 million acquisition, announced last week, will have "no impact" on Clinical Data's focus as a pharmacogenomics company, according to CEO Drew Fromkin.

Clinical Data will use the funds to support late-stage development of two of its drugs.

New Products: Feb 6, 2009

Premium

Aruna Biomedical

Snippets: Feb 4, 2009

Premium

National Institutes of Health, Genomic Health, Decode Genetics, Myriad Genetics, Exact Sciences, and more …

Pages

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.